BIO International Convention 2025

• Post by: admin
• 3:56PM Jun 23, 2025
• No Comment

KarisBio Showcases Next-Generation Cell Therapy at BIO USA 2025

KarisBio, a Yoon Lab biotech spinoff, recently participated in BIO USA 2025, the world’s largest biotechnology convention, where the company highlighted its innovative iPSC-derived cell therapy technologies.

• CEO Dr. Young-sup Yoon took the stage at the Korea Pavilion’s Corporate IR Session, sharing KarisBio’s clinical development strategies and vision for global partnerships.
• Seongho Bae, Director of KarisBio USA, presented at the Boston Biotechnology Summit, outlining the company’s U.S. expansion plans and opportunities for collaboration.

KarisBio continues to pave the way in next-generation cell therapy, driving forward new possibilities for regenerative medicine.